TLR7 and neoplasm: It was shown that 86% of mice vaccinated with cancer membrane‐coated nanoparticles remained tumor‐free survival for over 150 d, which was more efficient than a mixture of whole B16‐F10 cells and free CpG.133 In another example, researchers developed an APC‐targeted nanoparticle by using mannose‐modified cancer cell membranes and TLR7‐loaded PLGA nanoparticles.